Teraplast (TRP) investor relations material

Executive summary

• Revenue reached RON 1.083 billion in 2025, up 21% year-over-year, with volumes rising 12% to 123,423 tons, driven by Installations and Packaging divisions and supported by acquisitions and operational restructuring.

• EBITDA increased 75% to RON 86.7 million, with margin improving to 8%, including non-recurring income from asset sales.

• Net profit reached RON 1.2 million in 2025, reversing a significant loss from 2024.

• Sales outside Romania surged 59% to 34% of total revenue, reflecting regional expansion and reduced market dependency.

• Operational efficiency, integration of foreign subsidiaries, and visual rebranding drove performance improvements.

Financial highlights

• Gross margin rose to 38% in 2025, up 2 percentage points year-over-year, despite competitive and pricing pressures.

• Price deflation of 0.6% was offset by higher volumes and M&A contributions.

• Installations division remained the main growth driver, supported by public investment programs.

• Packaging division benefited from increased demand for biodegradable products and operational optimization.

• One-off gain of RON 8.5 million from sale of investment property contributed to results.

Outlook and guidance

• 2026 revenue budgeted at RON 1.26 billion, a 16% increase over 2025, with EBITDA expected at RON 102 million (8.1% margin) and net profit at RON 15.4 million.

• Sales volume target for 2026 is over 145,000 tons, up 18% year-over-year.

• Seasonality expected: losses in Q1 and Q4, profitability in Q2 and Q3.

• Focus remains on operational consolidation, external sales growth, and financial discipline amid uncertain public investment context.

• Continued integration of recent acquisitions and reduction of dependency on the Romanian market.